FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

49565007: Disopyramide phosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
82558017 Disopyramide phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
787257013 Disopyramide phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
34171000188117 disopyramide phosphate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
806781000172117 phosphate de disopyramide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Disopyramide phosphate Is a Product containing disopyramide (medicinal product) false Inferred relationship Some
Disopyramide phosphate Is a Disopyramide (substance) false Inferred relationship Some
Disopyramide phosphate Is a allergène médicamenteux false Inferred relationship Some
Disopyramide phosphate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Disopyramide (substance) true Inferred relationship Some
Disopyramide phosphate Is a Class Ia antiarrhythmic agent (substance) true Inferred relationship Some
Disopyramide phosphate Is a Pyridine true Inferred relationship Some
Disopyramide phosphate Is a Substance with sodium channel blocker mechanism of action (substance) true Inferred relationship Some
Disopyramide phosphate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sodium channel blocker true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Disopyramide phosphate 100mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Disopyramide phosphate 150mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Disopyramide phosphate 100mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Disopyramide phosphate 150mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Disopyramide phosphate 100mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Disopyramide phosphate Inferred relationship Some 1
Disopyramide phosphate 100mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Disopyramide phosphate 150mg prolonged-release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Disopyramide phosphate 100mg prolonged-release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Disopyramide phosphate Inferred relationship Some
Disopyramide (as disopyramide phosphate) 250 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Disopyramide phosphate Inferred relationship Some 1
Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Disopyramide phosphate Inferred relationship Some 1
Disopyramide (as disopyramide phosphate) 250 mg prolonged-release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide (as disopyramide phosphate) 50 milligram/5 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Disopyramide phosphate Inferred relationship Some 1
Disopyramide (as disopyramide phosphate) 10 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Disopyramide phosphate Inferred relationship Some 1
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Disopyramide phosphate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start